Financial Summary (All financials)
In millions, except per share items | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 |
Revenues | 3.3 | 3.6 | 4.4 | 4.8 |
Revenue growth | -8.4% | -17.7% | -8.1% | |
Cost of goods sold | 1.5 | 1.7 | 2.0 | 2.3 |
Gross profit | 1.8 | 2.0 | 2.4 | 2.5 |
Gross margin | 55.1% | 54.1% | 54.3% | 51.6% |
Sales and marketing | 1.0 | 1.2 | 1.7 | 1.8 |
Research and development | 0.6 | 0.6 | 0.7 | 0.6 |
General and administrative | 1.7 | 2.0 | 2.3 | 2.7 |
EBITA | -1.6 | -1.9 | -2.3 | -2.7 |
EBITA margin | -46.8% | -51.4% | -53.1% | -55.9% |
Amortization of intangibles | | | 0.0 | 0.0 |
EBIT | -1.6 | -1.9 | -2.4 | -2.7 |
EBIT margin | -46.8% | -51.4% | -54.0% | -56.7% |
Pre-tax income | -1.1 | -2.3 | -4.9 | -1.6 |
Income taxes | -7.4 | -0.3 | 0.0 | 0.0 |
Tax rate | 677.1% | 11.3% | 0.0% | 0.0% |
Net income | 6.3 | -2.0 | -4.9 | -1.6 |
Net margin | 189.1% | -56.2% | -110.6% | -33.3% |
|
Diluted EPS | $0.00 | ($0.08) | ($0.20) | ($0.07) |
Shares outstanding (diluted) | 24,940.9 | 24.8 | 24.7 | 24.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|